BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 10820004)

  • 1. Alternative splicing of Wilms' tumor suppressor protein modulates DNA binding activity through isoform-specific DNA-induced conformational changes.
    Laity JH; Chung J; Dyson HJ; Wright PE
    Biochemistry; 2000 May; 39(18):5341-8. PubMed ID: 10820004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression in Xenopus oocytes shows that WT1 binds transcripts in vivo, with a central role for zinc finger one.
    Ladomery M; Sommerville J; Woolner S; Slight J; Hastie N
    J Cell Sci; 2003 Apr; 116(Pt 8):1539-49. PubMed ID: 12640038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA Binding by the KTS Splice Variants of Wilms' Tumor Suppressor Protein WT1.
    Nishikawa T; Wojciak JM; Dyson HJ; Wright PE
    Biochemistry; 2020 Oct; 59(40):3889-3901. PubMed ID: 32955251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis for modulation of biological function by alternate splicing of the Wilms' tumor suppressor protein.
    Laity JH; Dyson HJ; Wright PE
    Proc Natl Acad Sci U S A; 2000 Oct; 97(22):11932-5. PubMed ID: 11050227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential function of Wilms' tumor gene WT1 splice isoforms in transcriptional regulation.
    Hewitt SM; Fraizer GC; Wu YJ; Rauscher FJ; Saunders GF
    J Biol Chem; 1996 Apr; 271(15):8588-92. PubMed ID: 8621487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel target for the Wilms' tumour suppressor protein (WT1) is bound by a unique combination of zinc fingers.
    Little MH; Holmes G; Pell L; Caricasole A; Duarte A; Law M; Ward A; Wainwright B
    Oncogene; 1996 Oct; 13(7):1461-9. PubMed ID: 8875984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of RNA aptamer binding by the Wilms' tumor suppressor protein WT1.
    Zhai G; Iskandar M; Barilla K; Romaniuk PJ
    Biochemistry; 2001 Feb; 40(7):2032-40. PubMed ID: 11329270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA recognition by splicing variants of the Wilms' tumor suppressor, WT1.
    Drummond IA; Rupprecht HD; Rohwer-Nutter P; Lopez-Guisa JM; Madden SL; Rauscher FJ; Sukhatme VP
    Mol Cell Biol; 1994 Jun; 14(6):3800-9. PubMed ID: 8196623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Products of alternatively spliced transcripts of the Wilms' tumor suppressor gene, wt1, have altered DNA binding specificity and regulate transcription in different ways.
    Wang ZY; Qiu QQ; Huang J; Gurrieri M; Deuel TF
    Oncogene; 1995 Feb; 10(3):415-22. PubMed ID: 7845666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA-induced alpha-helix capping in conserved linker sequences is a determinant of binding affinity in Cys(2)-His(2) zinc fingers.
    Laity JH; Dyson HJ; Wright PE
    J Mol Biol; 2000 Jan; 295(4):719-27. PubMed ID: 10656784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1.
    Borel F; Barilla KC; Hamilton TB; Iskandar M; Romaniuk PJ
    Biochemistry; 1996 Sep; 35(37):12070-6. PubMed ID: 8810912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Did nucleotides or amino acids drive evolutionary conservation of the WT1 +/-KTS alternative splice?
    Davies RC; Bratt E; Hastie ND
    Hum Mol Genet; 2000 May; 9(8):1177-83. PubMed ID: 10767342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recognition mechanism of Wilms' tumour suppressor protein and DNA triplets: insights from molecular dynamics simulation and free energy analysis.
    Zhang LF; Zheng QC; Zhang HX
    J Biomol Struct Dyn; 2019 Feb; 37(3):562-575. PubMed ID: 29375007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High affinity binding sites for the Wilms' tumour suppressor protein WT1.
    Hamilton TB; Barilla KC; Romaniuk PJ
    Nucleic Acids Res; 1995 Jan; 23(2):277-84. PubMed ID: 7862533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role for first zinc finger of WT1 in DNA sequence specificity: Denys-Drash syndrome-associated WT1 mutant in ZF1 enhances affinity for a subset of WT1 binding sites.
    Wang D; Horton JR; Zheng Y; Blumenthal RM; Zhang X; Cheng X
    Nucleic Acids Res; 2018 May; 46(8):3864-3877. PubMed ID: 29294058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Wilms' tumor gene WT1 can regulate genes involved in sex determination and differentiation: SRY, Müllerian-inhibiting substance, and the androgen receptor.
    Shimamura R; Fraizer GC; Trapman J; Lau YfC ; Saunders GF
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2571-80. PubMed ID: 9815658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of Wilms tumor WT1 splice variants on the insulin receptor promoter.
    Webster NJ; Kong Y; Sharma P; Haas M; Sukumar S; Seely BL
    Biochem Mol Med; 1997 Dec; 62(2):139-50. PubMed ID: 9441865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wilms' tumor 1 splice variants have opposite effects on the tumorigenicity of adenovirus-transformed baby-rat kidney cells.
    Menke AL; Riteco N; van Ham RC; de Bruyne C; Rauscher FJ; van der Eb AJ; Jochemsen AG
    Oncogene; 1996 Feb; 12(3):537-46. PubMed ID: 8637710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights into DNA-binding behavior of Wilms tumor protein (WT1)--a dual study.
    Nurmemmedov E; Yengo RK; Uysal H; Karlsson R; Thunnissen MM
    Biophys Chem; 2009 Dec; 145(2-3):116-25. PubMed ID: 19853363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two splice variants of the Wilms' tumor 1 gene have distinct functions during sex determination and nephron formation.
    Hammes A; Guo JK; Lutsch G; Leheste JR; Landrock D; Ziegler U; Gubler MC; Schedl A
    Cell; 2001 Aug; 106(3):319-29. PubMed ID: 11509181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.